In GCK-hyperglycemia, the need for higher total daily insulin doses — despite suboptimal HbA1c in the second trimester — highlights physiological resistance to insulin therapy due to homeostasis and supports the use of tailored approaches. The gene discussed is GCK; the disease is Hyperglycemia.